Early treatment response to mepolizumab predicts clinical remission in severe eosinophilic asthma.
Hamada Y, Gibson PG, Harvey ES, Stevens S, Lewthwaite H, Fricker M, McDonald VM, Gillman A, Hew M, Kritikos V, Upham JW, Thomas D.
Hamada Y, et al. Among authors: mcdonald vm.
J Allergy Clin Immunol Pract. 2024 Nov 6:S2213-2198(24)01160-7. doi: 10.1016/j.jaip.2024.10.041. Online ahead of print.
J Allergy Clin Immunol Pract. 2024.
PMID: 39515519